drugset / Trial / NCT06693609
Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This Phase 2 study (protocol number EMP-01-201) will determine the safety and tolerability of a short-term treatment with an oral dosage form of EMP-01 in adult participants with social anxiety disorder (SAD) and will assess exploratory efficacy of repeated doses of EMP-01 versus placebo.
Timeline
- Start
- 2025-04-15
- Primary completion
- 2026-02-12
- Completion
- 2026-02-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EMP-01 | Unknown | — | Oral |